IL52101A - Pharmaceutical compositions containing dihydroergotamine and etilefrine - Google Patents

Pharmaceutical compositions containing dihydroergotamine and etilefrine

Info

Publication number
IL52101A
IL52101A IL52101A IL5210177A IL52101A IL 52101 A IL52101 A IL 52101A IL 52101 A IL52101 A IL 52101A IL 5210177 A IL5210177 A IL 5210177A IL 52101 A IL52101 A IL 52101A
Authority
IL
Israel
Prior art keywords
etilefrine
pharmaceutical compositions
compositions containing
containing dihydroergotamine
dihydroergotamine
Prior art date
Application number
IL52101A
Other languages
English (en)
Other versions
IL52101A0 (en
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of IL52101A0 publication Critical patent/IL52101A0/xx
Publication of IL52101A publication Critical patent/IL52101A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D519/00Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • C07D519/02Ergot alkaloids of the cyclic peptide type
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/48Ergoline derivatives, e.g. lysergic acid, ergotamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IL52101A 1976-05-17 1977-05-16 Pharmaceutical compositions containing dihydroergotamine and etilefrine IL52101A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19762621906 DE2621906A1 (de) 1976-05-17 1976-05-17 Neue therapeutische mischung und verfahren zu deren herstellung

Publications (2)

Publication Number Publication Date
IL52101A0 IL52101A0 (en) 1977-07-31
IL52101A true IL52101A (en) 1980-01-31

Family

ID=5978199

Family Applications (1)

Application Number Title Priority Date Filing Date
IL52101A IL52101A (en) 1976-05-17 1977-05-16 Pharmaceutical compositions containing dihydroergotamine and etilefrine

Country Status (22)

Country Link
JP (1) JPS52139730A (xx)
AT (1) AT366574B (xx)
AU (1) AU513718B2 (xx)
BE (1) BE854694A (xx)
CA (1) CA1088865A (xx)
CS (1) CS207455B2 (xx)
DE (1) DE2621906A1 (xx)
ES (1) ES458819A1 (xx)
FR (1) FR2351657A1 (xx)
GB (1) GB1565447A (xx)
GR (1) GR72995B (xx)
HK (1) HK3283A (xx)
HU (1) HU175167B (xx)
IE (1) IE45197B1 (xx)
IL (1) IL52101A (xx)
MY (1) MY8400062A (xx)
NL (1) NL177981C (xx)
NZ (1) NZ184111A (xx)
PH (1) PH20257A (xx)
PT (1) PT66552B (xx)
SE (1) SE425545B (xx)
ZA (1) ZA772935B (xx)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2935515A1 (de) * 1979-09-03 1981-03-19 Fa. Dr. Willmar Schwabe, 7500 Karlsruhe Arzneipraeparat
JPH0227013U (xx) * 1988-08-10 1990-02-22
MXPA01009658A (es) 1999-03-26 2003-06-24 Pozen Inc Composiciones de dihidroergotamina de alta potencia.

Also Published As

Publication number Publication date
JPS628413B2 (xx) 1987-02-23
SE7705340L (sv) 1977-11-18
GR72995B (xx) 1984-01-24
IE45197L (en) 1977-11-17
PT66552A (en) 1977-06-01
CA1088865A (en) 1980-11-04
ATA347677A (de) 1981-09-15
ES458819A1 (es) 1978-08-01
GB1565447A (en) 1980-04-23
HU175167B (hu) 1980-05-28
DE2621906A1 (de) 1977-12-01
HK3283A (en) 1983-01-20
AU2516977A (en) 1978-11-23
NL177981C (nl) 1986-01-02
BE854694A (fr) 1977-11-16
CS207455B2 (en) 1981-07-31
IL52101A0 (en) 1977-07-31
NL7705306A (nl) 1977-11-21
MY8400062A (en) 1984-12-31
AU513718B2 (en) 1980-12-18
NZ184111A (en) 1980-02-21
NL177981B (nl) 1985-08-01
PH20257A (en) 1986-11-14
SE425545B (sv) 1982-10-11
AT366574B (de) 1982-04-26
ZA772935B (en) 1979-01-31
IE45197B1 (en) 1982-07-14
FR2351657B1 (xx) 1980-01-18
JPS52139730A (en) 1977-11-21
FR2351657A1 (fr) 1977-12-16
PT66552B (en) 1979-09-03
DE2621906C2 (xx) 1988-04-21

Similar Documents

Publication Publication Date Title
ZA771998B (en) Triazolo-pyrimidines and pharmaceutical compositions containing them
IL51660A0 (en) Hentriakontapeptides their preparation and pharmaceutical compositions containing them
NZ185356A (en) 1-aryloxy-2-hydroxy-3-alkyleneaminopropanes and pharmaceutical compositions containing them
NZ185986A (en) 2-oxa-bicyclic prostag-landins and pharmaceutical compositions
NZ183551A (en) Aminochromanols and pharmaceutical compositions containingthem
NZ185358A (en) Spiro-hydantoins and pharmaceutical compositions
NZ183134A (en) I-i-(3-aryloxy-2-hydroxypropyl)-4-piperidyl-3-aryl-imid-azolidin or hexahydropyrimidin-2-ones; and pharmaceutical compositions
NZ184428A (en) N-acyl-l-alanyl-aminoacyl-amides untermediates and pharmaceutical compositions
IL52433A (en) 2-bromo-6-fluoro-n-2-imidazolidinylidene-benzamine and pharmaceutical compositions containing them
JPS5315367A (en) 22benzilpyrrolidine* preparation thereof and medicine containing same
JPS52111552A (en) 44androstenee33one and preparation thereof
NZ184912A (en) 2-phenylamino-imidazolines and pharmaceutical compositions
JPS5362834A (en) Pharmaceutical composition and use thereof
NZ184735A (en) Peptides and pharmaceutical compositions
IL52409A (en) 5-m-tolyloxyuracil and pharmaceutical compositions containing it
IL51572A0 (en) New substituted purines and pharmaceutical compositions containing them
NZ183549A (en) Amidinopencillanoyloxy-alkyl-amoxycillinates and pharmaceutical compositions
PH12590A (en) 4a-aryl octahydro-1h-2-pyrindines and pharmaceutical composition thereof
NZ185296A (en) Corticoids and pharmaceutical compositions
NZ185341A (en) 19-oxygenated steroids and pharmaceutical compositions
JPS5320433A (en) Pharmaceutical composition and application
JPS52131534A (en) Aralkylarylamine and preparation thereof
JPS5291859A (en) 22furanones and preparation thereof
IL52101A (en) Pharmaceutical compositions containing dihydroergotamine and etilefrine
NZ183756A (en) Bis-penicillanoyloxy-alkanes and pharmaceutical compositions